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Essay
D
espite intensive use of the term 
mild cognitive impairment 
(MCI) to describe an 
intermediate stage of cognitive decline 
between normal and pathological brain 
ageing, no formally agreed process 
of characterising this condition exists 
[1–3]. Various deﬁnitions have been 
proposed in the literature, each with 
differences in focus (e.g., age-associated 
change versus pathological decline) 
and non-uniform diagnostic criteria 
[4–18]. The degree of inconsistency 
is not trivial: current classiﬁcations 
deﬁne heterogeneous populations with 
different patterns of aetiology, cognitive 
decline, and clinical outcome [19]. 
As an opportunity for identifying 
individuals at risk of developing 
dementia, MCI is an important 
concept. Yet lack of consensus 
criteria has lead to debate about 
the utility of MCI, resulting in calls 
for abandoning its diagnosis and 
adopting an alternative nosology 
[20–22]. Consensus conferences are 
now being held, even though MCI 
diagnoses are already used in clinical 
trials for prevention of Alzheimer 
disease [23]. The aim of this paper is to 
develop a framework for mapping the 
different classiﬁcations of MCI using 
retrospective information, assessing 
variations in deﬁning criteria.
Creating a Framework for Mapping 
MCI
The ﬁrst step to coding MCI is to 
determine the necessary criteria and 
thresholds for operationalisation 
of each deﬁnition. We compiled 
a comprehensive list of those 
classiﬁcations which represent different 
aspects and deﬁnitions of MCI. The 
necessary components for each were 
abstracted and formulated into a 
diagnostic algorithm. 
The main problem encountered was 
that while some classiﬁcations have 
speciﬁc criteria for implementation 
(e.g., amnestic MCI [A-MCI] [13,14] 
and age-associated memory impairment 
[5]), others are vague descriptions 
that require interpretation as to 
the exact nature of the deﬁcit (e.g., 
age-related cognitive decline [24]). 
Further complicating the problem is 
a lack of speciﬁcation of screening 
tools and variability in: (1) the domain 
of impairment (memory versus non-
memory, single- versus multi-domain 
deﬁcits); (2) cut-off scores; (3) 
acceptable restriction on activities of 
daily living; and (4) exclusion criteria.
Eighteen current deﬁnitions of early 
cognitive impairment were identiﬁed in 
a systematic review of the literature and 
mapped using a ﬂow diagram as shown 
in Figure 1. Mapping is completed 
in two phases: following exclusion of 
all individuals with dementia, each 
classiﬁcation is then operationalised 
independently. Each classiﬁcation 
could be constructed from a subset 
of 15 different criteria, with memory 
impairment required as an essential 
feature in almost all classiﬁcations. 
Surprisingly, no two classiﬁcation 
systems map on the same path. Each 
classiﬁcation is operationalised in the 
population and has been previously 
applied to the Medical Research 
Council Cognitive Function and 
Ageing Study (MRC CFAS) [19]. Table 
1 outlines how each set of criteria was 
operationalised in CFAS. To facilitate 
cross classiﬁcation comparisons, criteria 
were consistent in terms of level of 
impairment unless cut-off thresholds 
were uniquely speciﬁed.
In reading the ﬂow diagram, the 
classiﬁcation arrived at depends on the 
direction of decision at each criteria 
(yes, criteria required are fulﬁlled as 
indicated by a green arrow, or no,
criteria are not fulﬁlled as indicated 
by a red arrow). If an individual fails 
to meet the speciﬁed outcome for a 
given criterion they are excluded from 
further mapping. 
Two Examples: Benign Senescent 
Forgetfulness and A-MCI
For example, following the ﬂow 
diagram to arrive at a classiﬁcation 
of benign senescent forgetfulness 
(BSF) takes just three steps: from 
the “START” box you move to the 
“Demented” box. If the individual does 
not have dementia (as indicated by the 
red arrow), you next move to the “Long-
Term Memory Problem” box, and if the 
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individual shows a long-term memory 
problem with intact recent memory (as 
indicated by the green arrow), you then 
arrive at a classiﬁcation of BSF. (See 
Figure 2 for the BSF-speciﬁc path.) 
In contrast, to arrive at a 
classiﬁcation of A-MCI, seven steps 
are needed: (1) the individual is 
not demented (as indicated by the 
red arrow); (2) there is an objective 
memory impairment (one standard 
deviation below age-corrected norms, 
as indicated by the green arrow); 
(3) the individual or an informant 
complains of memory loss (as indicated 
by the green arrow); (4) there is no 
impairment in activities of daily living 
(as indicated by the red arrow); (5) 
there is no impairment of general 
cognitive functioning (as indicated by 
the red arrow); (6) the individual has 
no underlying medical or neurological 
condition (as indicated by the red 
arrow); and (7) there is no impairment 
in another non-memory domain (as 
indicated by the red arrow). (See 
Figure 3 for the A-MCI-speciﬁc path.) 
Advantages and Disadvantages
The ﬂow diagram details this 
process for each of the 18 different 
classiﬁcation systems, allowing for 
reproduction across studies. Each 
concept has been detailed in turn 
with a criteria-speciﬁc graph and 
the appropriate references on the 
CFAS Web site (http://www.cfas.
ac.uk/mciprogram/). The clinical 
utility of the concept of mild cognitive 
impairment depends on the validity 
of the diagnosis and the ability to 
predict higher rates of progression 
to dementia. The advantage of 
retrospective deﬁnition of these 
concepts is that they are not adjusted 
by current knowledge or changing 
criteria, an unfortunate downside 
of consensus criteria being that 
they can be inﬂuenced by changing 
knowledge over time. The disadvantage 
of mapping with retrospective 
information is that it removes clinical 
experience from the deﬁnition, and 
the information measured from all 
individuals must have enough scope 
to encompass the entire original 
deﬁnition.
A fundamental problem with a 
multiple system approach is the 
failure in consistency of classiﬁcation. 
Prevalence estimates for each 
classiﬁcation have been previously 
calculated in CFAS using the pathways 
doi:10.1371/journal.pmed.0040304.g001
Figure 1. Schematic Overview of the Approach Used to Classify MCI across Different Deﬁnitions in the Medical Research Council Cognitive 
Function and Ageing Study 
AACD, age-associated cognitive decline; AAMI, age-associated memory impairment; ACMI, age-consistent memory impairment; ARCD, age-related 
cognitive decline; CIND, cognitive impairment no dementia; DEM, dementia; LCD, limited cognitive disturbance; MCD (ICD-10), mild cognitive disorder 
(International Classiﬁcation of Diseases 10th Revision); MCDi (GDS3), mild cognitive decline (Global Deterioration Scale Stage 3); MCDo(GDS4), moderate 
cognitive decline (Global Deterioration Scale Stage 4); MD, minimal dementia; M-MCI, multiple mild cognitive impairment; MMSE, Mini Mental State 
Examination Cut-off Scores; MNCD, mild neurocognitive disorder; N-MCI, non-amnestic mild cognitive impairment; QD, questionable dementia; SD, 
standard deviation; SMC, self-reported memory complaint.PLoS Medicine  |  www.plosmedicine.org 1617 October 2007  |  Volume 4  |  Issue 10  |  e304
shown in Figure 1, and were found to 
be highly variable (range 0.1%–42%) 
[19]. Some of this difference results 
from the fact that not all criteria 
explain pathological ageing, but 
rather “normal” ageing. Although the 
distinction between those deﬁnitions 
associated with normal age-related 
change and those with pathological 
ageing is not apparent from prevalence 
estimates alone, it is seen with lower 
conversion to dementia in those 
groups deﬁned by non-pathological 
classiﬁcations. Furthermore, the 
same individual could be classiﬁed as 
impaired on one system and normal 
on another, even within criteria that 
are supposedly investigating abnormal 
change. This makes the interpretation 
and comparison of results across 
studies very difﬁcult, where not only 
the populations but additionally the 
criteria chosen to estimate MCI are 
different.
At ﬁrst glance, a solution to the 
complexity of the diagram appears 
simple: reduce all classiﬁcation 
Table 1. Operationalisation of Components of Classiﬁcation Systems in the Medical Research Council Cognitive 
Function and Ageing Study
Criteria Operationalisation
Dementia AGECAT organic symptom level ≥3. This corresponds to a diagnosis of dementia as deﬁned by DSM-III-R [25].
Long-term memory intact/short-term memory impaired CAMCOG remote memory score below the 16th centile score and recent memory score greater than the 16th 
centile score.
Subjective memory complaint Self or informant report. Combined score created from three questions including: (1) Have you had any 
difﬁculty with your memory? (self report); (2) Have you tended to forget things recently? (self report); and (3) 
Has he/she had any difﬁculty with his/her memory? (informant report). Responses dichotomised into “non-
complainers” or “complainers” (positive response to one or more questions).
Exclusions Unique to each classiﬁcation. Could include any combination of the following: history of heart attack, chest 
pain, angina, stroke, Parkinson disease, intermittent claudication, emotional problems, diabetes mellitus, 
asthma, arthritis, meningitis, head injury, thyroid problems, pernicious anaemia, depression, anxiety, chronic 
bronchitis, and high blood pressure.
General cognitive decline Mini Mental Examination (MMSE) score ≤21.
Gradual decline (present for at least six months) One or more positive responses to the following memory questions, with decline reported as being gradual: 
(1) Do you have to make more effort to remember things than you used to? What sort of things?; (2) When did 
you notice this beginning?; (3) Did it come on suddenly?; (4) Would you say there has been a deterioration 
of memory over a period of more than two years?; and (5) Did these problems with memory begin rapidly or 
gradually?
Minor errors in orientation CAMCOG orientation subtest score below the 16th centile score.
Clinical problem (i.e., depression or anxiety) Depression and anxiety both deﬁned as AGECAT symptom level ≥3.
Other (non-memory) cognitive impairment Below threshold on one or more of the following subtests of the CAMCOG: orientation, language, attention/
calculation, praxis, abstract thinking, and perception.
Impaired activities of daily living Modiﬁed Townsend Disability Scale, with an additional three items. Impairment deﬁned as requiring help at 
least several times per week with washing, cooking, and dressing, or as being housebound.
Mental status questionnaire Maximum score of 10 derived from the following questions: (1) What is the name of this place? Where is it 
located? (2 points); (2) What is the date today? (1 point); (3) What is the month? (1 point); (4) What is the year? 
(1 point); (5) How old are you? (1 point); (6) What is your date of birth (day/month)? (2 points); (7) What is the 
name of the prime minister? (1 point); (8) Who was the last prime minister? (1 point).
Objective memory impairment Below threshold on one or more of the following memory subtests of the CAMCOG: learning, recent, or 
remote memory.
Forgetfulness Positive response to one or more of the following questions: (1) Do you forget the names of your family and 
friends?; (2) Do you forget where you have placed things?
AGECAT, automatic geriatric examination for computer assistedtaxonomy; CAMCOG, Cambridge Cognitive Examination; DSM-III-R,  Diagnostic and Statistical Manual of Mental Disorders, 
Third Edition, Revised; MMSE, Mini Mental State Examination Cut-off Scores.
doi:10.1371/journal.pmed.0040304.t001
doi:10.1371/journal.pmed.0040304.g002
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systems to a single concept through 
the amalgamation of all deﬁning 
criteria, particularly the measurement 
of objective memory and the medical 
(and disability) exclusion criteria. 
However, this solution assumes that 
within these criteria there is one that 
is the best for identiﬁcation of at-risk 
individuals. Furthermore, deﬁnitions, 
particularly those of objective cognitive 
impairment, depend on arbitrary and 
varying thresholds, frequently with no 
reference to speciﬁc values, methods, 
or screening measures. In retrospective 
studies, the mapping of these 
thresholds will primarily be constrained 
by study design, though the use of 
different thresholds can be used to 
determine the most optimal threshold 
value to accurately distinguish those 
individuals at high risk of dementia 
from those with low dementia risk.
Conclusion
It is time to re-examine the concept of 
MCI. The diagnostic disparity and the 
lack of consistency in case deﬁnition 
calls into question what exactly is 
being captured in each classiﬁcation. 
This is a fundamental weakness of 
research on MCI, as highlighted by 
the complicated nature of Figure 1. 
Using this ﬂow diagram, MCI systems 
can be mapped in other population 
datasets to investigate: (1) what are 
the best boundaries for impairment; 
(2) which tests are most sensitive for 
measuring each criteria; (3) which 
criteria, if any, can adequately predict 
individuals at risk of developing 
dementia; and (4) would adopting 
multiple systems across different 
populations (specialist clinic versus 
population based) and age groups 
be more appropriate? It is hoped 
that graphical operationalisation 
of the criteria will aid in diagnostic 
consistency and assist in the 
visualisation of the current problem, 
with the aim of formulating a gold 
standard deﬁnition for both research 
and clinical practice.  
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